Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocritical Care: A New Alternative?

Author： Fields Jeremy  

Publisher： Humana Press, Inc

ISSN： 1541-6933

Source： Neurocritical Care, Vol.11, Iss.1, 2009-08, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conivaptan for Hyponatremia in the Neurocritical Care Unit

By Wright Wendy  

Neurocritical Care, Vol. 11, Iss. 1, 2009-08 ,pp. : 6-13

Humana Press, Inc

Access to resources Recommend Favorite

New Approaches to Physiological Informatics in Neurocritical Care

By Sorani Marco   Hemphill J.   Morabito Diane   Rosenthal Guy   Manley Geoffrey  

Neurocritical Care, Vol. 7, Iss. 1, 2007-08 ,pp. : 45-52

Humana Press, Inc

Access to resources Recommend Favorite

Mechanisms, Risks, and New Treatment Options for Hyponatremia

By  

Cardiology, Vol. 111, Iss. 3, 2008-04 ,pp. : 147-157

Karger

Access to resources Recommend Favorite

Is simple nephrectomy truly simple? Comparison with the radical alternative

By Connolly S.  

Irish Journal of Medical Science, Vol. 180, Iss. 1, 2011-03 ,pp. : 177-179

Springer Publishing Company

Access to resources Recommend Favorite

Arginine Vasopressin and Osmolality in the Elderly

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 4, 1994-04 ,pp. : 399-404

John Wiley & Sons Inc

Access to resources Recommend Favorite